Biblio Discovery — Demo Discovery Service

11 hasil untuk "Mark Atkinson"

Menampilkan 1–11 · 0,41 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Speaker Input Variability Does Not Explain Why Larger Populations Have Simpler Languages

    Mark Atkinson; Simon Kirby; Kenny Smith

    PLOS ONE, Vol. 10 No. 6 · 2015 · Inggris · PLOS Scopus

    A learner’s linguistic input is more variable if it comes from a greater number of speakers. Higher speaker input variability has been shown to facilitate the acquisition of phonemic boundaries, since data drawn from multiple speakers provides more information about the distribution of phonemes in…

  2. Artikel Jurnal Teks lengkap

    Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method

    Betty Tao; Massimo Pietropaolo; Mark Atkinson dkk.

    PLoS ONE, Vol. 5 No. 7 · 2010 · Inggris · PLOS Scopus

    Background: Diabetes costs represent a large burden to both patients and the health care system. However, few studies that examine the economic consequences of diabetes have distinguished between the two major forms, type 1 and type 2 diabetes, despite differences in underlying pathologies…

  3. Artikel Jurnal Teks lengkap

    Limited evidence for executive function load impairing selective copying in a win-stay lose-shift task

    Juliet Dunstone; Mark Atkinson; Catherine Grainger dkk.

    PLOS ONE, Vol. 16 No. 3 · 2021 · Inggris · PLOS Scopus

    The use of ‘explicitly metacognitive’ learning strategies has been proposed as an explanation for uniquely human capacities for cumulative culture. Such strategies are proposed to rely on explicit, system-2 cognitive processes, to enable advantageous selective copying. To investigate the…

  4. Artikel Jurnal Teks lengkap

    Association of Diabetes in Pregnancy with Child Weight at Birth, Age 12 Months and 5 Years – A Population-Based Electronic Cohort Study

    Kelly Morgan; Mohammed Rahman; Mark Atkinson dkk.

    PLoS ONE, Vol. 8 No. 11 · 2013 · Inggris · PLOS Scopus

    Background: This study examines the effect of diabetes in pregnancy on offspring weight at birth and ages 1 and 5 years. Methods: A population-based electronic cohort study using routinely collected linked healthcare data. Electronic medical records provided maternal diabetes status and offspring…

  5. Artikel Jurnal Teks lengkap

    Development of strategic social information seeking: Implications for cumulative culture

    Kirsten H. Blakey; Eva Rafetseder; Mark Atkinson dkk.

    PLOS ONE, Vol. 16 No. 8 · 2021 · Inggris · PLOS Scopus

    Human learners are rarely the passive recipients of valuable social information. Rather, learners usually have to actively seek out information from a variety of potential others to determine who is in a position to provide useful information. Yet, the majority of developmental social learning…

  6. Artikel Jurnal Teks lengkap

    The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice

    Abdoreza Davoodi-Semiromi; Clive H. Wasserfall; Chang Qing Xia dkk.

    PLoS ONE, Vol. 7 No. 5 · 2012 · Inggris · PLOS Scopus

    Background: Recent studies in the NOD (non-obese diabetic) mouse model of type 1 diabetes (T1D) support the notion that tyrosine kinase inhibitors have the potential for modulating disease development. However, the therapeutic effects of AG490 on the development of T1D are unknown. Materials and…

  7. Artikel Jurnal Teks lengkap

    Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet Transplantation

    Nicola Gagliani; Silvia Gregori; Tatiana Jofra dkk.

    PLoS ONE, Vol. 6 No. 12 · 2011 · Inggris · PLOS Scopus

    Background: A large pool of preexisting alloreactive effector T cells can cause allogeneic graft rejection following transplantation. However, it is possible to induce transplant tolerance by altering the balance between effector and regulatory T (Treg) cells. Among the various Treg-cell types…

  8. Artikel Jurnal Teks lengkap

    Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank

    Sophie V Eastwood; Rohini Mathur; Mark Atkinson dkk.

    PLOS ONE, Vol. 11 No. 9 · 2016 · Inggris · PLOS Scopus

    Objectives: UK Biobank is a UK-wide cohort of 502,655 people aged 40–69, recruited from National Health Service registrants between 2006–10, with healthcare data linkage. Type 2 diabetes is a key exposure and outcome. We developed algorithms to define prevalent and incident diabetes for UK Biobank…

  9. Artikel Jurnal Teks lengkap

    Persistent STAT5 Phosphorylation and Epigenetic Dysregulation of GM-CSF and PGS2/COX2 Expression in Type 1 Diabetic Human Monocytes

    Erin Garrigan; Nicole S. Belkin; John J. Alexander dkk.

    PLoS ONE, Vol. 8 No. 10 · 2013 · Inggris · PLOS Scopus

    STAT5 proteins are adaptor proteins for histone acetylation enzymes. Histone acetylation at promoter and enhancer chromosomal regions opens the chromatin and allows access of transcription enzymes to specific genes in rapid response cell signals, such as in inflammation. Histone…

  10. Artikel Jurnal Teks lengkap

    Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis

    Shang-Ming Zhou; Fabiola Fernandez-Gutierrez; Jonathan Kennedy dkk.

    PLOS ONE, Vol. 11 No. 5 · 2016 · Inggris · PLOS Scopus

    Objectives: 1) To use data-driven method to examine clinical codes (risk factors) of a medical condition in primary care electronic health records (EHRs) that can accurately predict a diagnosis of the condition in secondary care EHRs. 2) To develop and validate a disease phenotyping algorithm for…

  11. Artikel Jurnal Teks lengkap

    Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice

    Ghanashyam Sarikonda; Sowbarnika Sachithanantham; Yulia Manenkova dkk.

    PLoS ONE, Vol. 8 No. 2 · 2013 · Inggris · PLOS Scopus

    A recent type 1 diabetes (T1D) clinical trial of rituximab (a B cell-depleting anti-CD20 antibody) achieved some therapeutic benefit in preserving C-peptide for a period of approximately nine months in patients with recently diagnosed diabetes. Our previous data in the NOD mouse demonstrated that…